FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205736230> ?p ?o ?g. }

• W3205736230 endingPage "e001725" @default.
• W3205736230 startingPage "e001725" @default.
• W3205736230 abstract "Objective To optimise treatment of patients with pulmonary arterial hypertension (PAH), the 2015 European Society of Cardiology/European Respiratory Society guidelines recommend using risk stratification, with the aim of patients achieving low-risk status. Previous analyses of registries made progress in using risk stratification approaches, however, the focus is often on patients with a low-risk prognosis, whereas most PAH patients are in intermediate-risk or high-risk categories. Using only six parameters with high prognostic relevance, we aimed to demonstrate a pragmatic approach to individual patient risk assessment to discriminate between patients at low risk, intermediate risk and high risk of death. Methods Risk assessment was performed combining six parameters in four criteria: (1) WHO functional class, (2) 6 min walk distance, (3) N-terminal pro-brain natriuretic peptide (BNP)/BNP plasma levels or right atrial pressure and (4) cardiac index or mixed venous oxygen saturation. Assessments were made at baseline and at first follow-up after 3–4 months. Results 725 PAH treatment-naive patients were analysed. Survival estimates between risk groups were statistically significant at baseline and first follow-up (p<0.001), even when the analysis was performed within PAH etiological subgroups. Similar results were observed in 208 previously treated PAH patients. Furthermore, patients who remained at or improved to low risk had a significantly better estimated survival compared with patients who remained at or worsened to intermediate risk or high risk (p≤0.005). Conclusion The simplified risk-assessment method can discriminate idiopathic, connective-tissue-disease-associated and congenital-heart-disease-associated PAH patients into meaningful high-risk, intermediate-risk and low-risk groups at baseline and first follow-up. This pragmatic approach reinforces targeting a low-risk profile for PAH patients." @default.
• W3205736230 created "2021-10-25" @default.
• W3205736230 creator A5000903509 @default.
• W3205736230 creator A5005517026 @default.
• W3205736230 creator A5030686532 @default.
• W3205736230 creator A5038149615 @default.
• W3205736230 creator A5042871928 @default.
• W3205736230 creator A5047253560 @default.
• W3205736230 creator A5047331276 @default.
• W3205736230 creator A5050603111 @default.
• W3205736230 creator A5065469571 @default.
• W3205736230 creator A5066093039 @default.
• W3205736230 creator A5067333030 @default.
• W3205736230 creator A5079761805 @default.
• W3205736230 date "2021-10-01" @default.
• W3205736230 modified "2023-10-14" @default.
• W3205736230 title "A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines" @default.
• W3205736230 cites W1866413456 @default.
• W3205736230 cites W1921232148 @default.
• W3205736230 cites W1984693219 @default.
• W3205736230 cites W2010442680 @default.
• W3205736230 cites W2096751910 @default.
• W3205736230 cites W2103896976 @default.
• W3205736230 cites W2114374604 @default.
• W3205736230 cites W2117339256 @default.
• W3205736230 cites W2127994875 @default.
• W3205736230 cites W2129125190 @default.
• W3205736230 cites W2151863430 @default.
• W3205736230 cites W2169337689 @default.
• W3205736230 cites W2288033263 @default.
• W3205736230 cites W2606984277 @default.
• W3205736230 cites W2621229357 @default.
• W3205736230 cites W2743897368 @default.
• W3205736230 cites W2744074505 @default.
• W3205736230 cites W2781377718 @default.
• W3205736230 cites W2783839364 @default.
• W3205736230 cites W2794463525 @default.
• W3205736230 cites W2794523607 @default.
• W3205736230 cites W2800614942 @default.
• W3205736230 cites W2911671206 @default.
• W3205736230 cites W4292528167 @default.
• W3205736230 doi "https://doi.org/10.1136/openhrt-2021-001725" @default.
• W3205736230 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8527122" @default.
• W3205736230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34667092" @default.
• W3205736230 hasPublicationYear "2021" @default.
• W3205736230 type Work @default.
• W3205736230 sameAs 3205736230 @default.
• W3205736230 citedByCount "3" @default.
• W3205736230 countsByYear W32057362302022 @default.
• W3205736230 countsByYear W32057362302023 @default.
• W3205736230 crossrefType "journal-article" @default.
• W3205736230 hasAuthorship W3205736230A5000903509 @default.
• W3205736230 hasAuthorship W3205736230A5005517026 @default.
• W3205736230 hasAuthorship W3205736230A5030686532 @default.
• W3205736230 hasAuthorship W3205736230A5038149615 @default.
• W3205736230 hasAuthorship W3205736230A5042871928 @default.
• W3205736230 hasAuthorship W3205736230A5047253560 @default.
• W3205736230 hasAuthorship W3205736230A5047331276 @default.
• W3205736230 hasAuthorship W3205736230A5050603111 @default.
• W3205736230 hasAuthorship W3205736230A5065469571 @default.
• W3205736230 hasAuthorship W3205736230A5066093039 @default.
• W3205736230 hasAuthorship W3205736230A5067333030 @default.
• W3205736230 hasAuthorship W3205736230A5079761805 @default.
• W3205736230 hasBestOaLocation W32057362301 @default.
• W3205736230 hasConcept C12174686 @default.
• W3205736230 hasConcept C126322002 @default.
• W3205736230 hasConcept C164705383 @default.
• W3205736230 hasConcept C177713679 @default.
• W3205736230 hasConcept C2775846464 @default.
• W3205736230 hasConcept C2775915353 @default.
• W3205736230 hasConcept C2778198053 @default.
• W3205736230 hasConcept C2780930700 @default.
• W3205736230 hasConcept C3020404979 @default.
• W3205736230 hasConcept C38652104 @default.
• W3205736230 hasConcept C41008148 @default.
• W3205736230 hasConcept C71924100 @default.
• W3205736230 hasConceptScore W3205736230C12174686 @default.
• W3205736230 hasConceptScore W3205736230C126322002 @default.
• W3205736230 hasConceptScore W3205736230C164705383 @default.
• W3205736230 hasConceptScore W3205736230C177713679 @default.
• W3205736230 hasConceptScore W3205736230C2775846464 @default.
• W3205736230 hasConceptScore W3205736230C2775915353 @default.
• W3205736230 hasConceptScore W3205736230C2778198053 @default.
• W3205736230 hasConceptScore W3205736230C2780930700 @default.
• W3205736230 hasConceptScore W3205736230C3020404979 @default.
• W3205736230 hasConceptScore W3205736230C38652104 @default.
• W3205736230 hasConceptScore W3205736230C41008148 @default.
• W3205736230 hasConceptScore W3205736230C71924100 @default.
• W3205736230 hasIssue "2" @default.
• W3205736230 hasLocation W32057362301 @default.
• W3205736230 hasLocation W32057362302 @default.
• W3205736230 hasLocation W32057362303 @default.
• W3205736230 hasLocation W32057362304 @default.
• W3205736230 hasLocation W32057362305 @default.
• W3205736230 hasOpenAccess W3205736230 @default.
• W3205736230 hasPrimaryLocation W32057362301 @default.
• W3205736230 hasRelatedWork W11304534 @default.
• W3205736230 hasRelatedWork W1652175796 @default.

• next